India's first dengue vaccine gets approval for clinical trial

Indian Immunological Limited (IIL), got the permit for Phase-1 of the dengue vaccine

FPJ Web DeskUpdated: Thursday, September 15, 2022, 03:34 PM IST
article-image
Representative image | File

One of the leading vaccine manufacturers, Indian Immunological Limited (IIL), has received the permit for Phase-1 of the dengue vaccine. This vaccine is being developed with the collaboration with the US-based National Institute of Health.

In April, India and the Council of Medical Research (ICMR) entered the market to create a dengue vaccine.

According to reportss, Panacea Biotec Limited and Sanofi India Private Limited are currently working on two other potential vaccines while awaiting their clinical trials.

Data from the National Center for Vector Borne Diseases Control (NCVBDC) reveal India had 1,93,245 cases of dengue and 346 deaths last year. The main causes of dengue are water logging, heavy rainfall, poor drainage, and unhygienic surroundings as a result, cities like Mumbai and Delhi experience an increase in dengue cases.

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Suffering from PCOS? Four foods to include in your diet right now

Suffering from PCOS? Four foods to include in your diet right now

Mumbai doctors perform complex bypass surgery, give Vasai resident a new lease of life

Mumbai doctors perform complex bypass surgery, give Vasai resident a new lease of life

Control sweet cravings and manage weight gain with Sujok during the festive season

Control sweet cravings and manage weight gain with Sujok during the festive season

How Yoni Mudra can help children cope with physical and emotional changes during puberty

How Yoni Mudra can help children cope with physical and emotional changes during puberty

Alzheimer's: Drug being developed by Biogen and Eisai shows some positive results

Alzheimer's: Drug being developed by Biogen and Eisai shows some positive results